BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32808277)

  • 1. Overexpression of STAT4 at early stages of mycosis fungoides: Coincidence or not?
    Olisova OY; Grekova EV; Zaletaev DV; Alekseeva EA
    Australas J Dermatol; 2021 Feb; 62(1):e119-e120. PubMed ID: 32808277
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic markers associated with progression in early mycosis fungoides.
    Johnson VE; Vonderheid EC; Hess AD; Eischen CM; McGirt LY
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1431-5. PubMed ID: 24171863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycosis fungoides with focal CD 30 transformation in an adolescent.
    Romero M; Haney M; Desantis E; Zlotoff B
    Pediatr Dermatol; 2008; 25(5):565-8. PubMed ID: 18950403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confocal microscopy features of patch-stage mycosis fungoides and their correlation with horizontal histopathological sections. A case series.
    Broggi G; Lacarrubba F; Verzì AE; Micali G; Caltabiano R
    J Cutan Pathol; 2019 Feb; 46(2):163-165. PubMed ID: 30387175
    [No Abstract]   [Full Text] [Related]  

  • 5. TOX, TWIST1, STAT4, and SATB1 protein expressions in early-stage mycosis fungoides.
    Örnek S; Ozekinci S; Ipin T; Kocaturk E
    J Cutan Pathol; 2024 Mar; 51(3):232-238. PubMed ID: 37932931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Stage Mycosis Fungoides in a Child.
    Dulmage BO; Villaseñor-Park J; Ho J; Geskin LJ; Grandinetti LM
    Pediatr Dermatol; 2015; 32(4):e156-8. PubMed ID: 25892093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudotumorous folliculotropic mycosis fungoides.
    Kossard S; Weller P
    Am J Dermatopathol; 2005 Jun; 27(3):224-7. PubMed ID: 15900126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.
    Alcántara-Hernández M; Torres-Zárate C; Pérez-Montesinos G; Jurado-Santacruz F; Domínguez-Gómez MA; Peniche-Castellanos A; Ferat-Osorio E; Neri N; Nambo MJ; Alvarado-Cabrero I; Moreno-Lafont M; Huerta-Yepez S; Bonifaz LC
    Int J Cancer; 2014 May; 134(9):2136-45. PubMed ID: 24127318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.
    Roberts AA; Amano M; Felten C; Galvan M; Sulur G; Pinter-Brown L; Dobbeling U; Burg G; Said J; Baum LG
    Mod Pathol; 2003 Jun; 16(6):543-51. PubMed ID: 12808059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus and activation-regulated chemokine in different stages of mycosis fungoides: tissue and serum levels.
    Abou El-Ela M; El-Rifae Ael-A; Fawzi M; Abdel Hay R; Gohary Y; Shaker O
    Australas J Dermatol; 2011 Aug; 52(3):167-71. PubMed ID: 21834810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulomatous slack skin: a case of unusual variant of mycosis fungoides.
    Chen M; Qiu B; Kong J
    Chin Med J (Engl); 2000 Feb; 113(2):189-92. PubMed ID: 11775552
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypopigmented mycosis fungoides in an adolescent Turkish boy.
    Gülekon A; Ozsoy E; Gürer MA; Ataoģlu O
    Int J Dermatol; 2005 Sep; 44(9):795-6. PubMed ID: 16135159
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma.
    Gao C; McCormack CJ; van der Weyden C; Twigger R; Buelens O; Lade S; Khoo C; Campbell BA; Goh M; McKelvie P; Prince HM
    J Am Acad Dermatol; 2021 Jan; 84(1):185-187. PubMed ID: 32334059
    [No Abstract]   [Full Text] [Related]  

  • 14. CD8-positive pityriasis lichenoides-like mycosis fungoides.
    Cho EB; Youn SH; Park EJ; Kwon IH; Kim KH; Kim KJ
    Eur J Dermatol; 2012; 22(3):415-6. PubMed ID: 22614934
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of CD30+ large-cell transformation in a patient with unilesional patch-stage mycosis fungoides.
    Ohtani T; Kikuchi K; Koizumi H; Kunii T; Aiba S
    Int J Dermatol; 2009 Jun; 48(6):623-6. PubMed ID: 19538373
    [No Abstract]   [Full Text] [Related]  

  • 16. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.
    Nielsen M; Kaltoft K; Nordahl M; Röpke C; Geisler C; Mustelin T; Dobson P; Svejgaard A; Odum N
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6764-9. PubMed ID: 9192639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides with spontaneously regressing CD30-positive tumorous lesions.
    Woodrow SL; Basarab T; Russell Jones R
    Clin Exp Dermatol; 1996 Sep; 21(5):370-3. PubMed ID: 9136160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic expression analysis of mycosis fungoides (MF) skin tissues: overexpressions of SOD2, S100A8 and FABP5 in MF.
    Liu J; Zeng Y; Zhou Y; Ma D; Wang B
    J Dermatol Sci; 2010 Oct; 60(1):42-4. PubMed ID: 20833513
    [No Abstract]   [Full Text] [Related]  

  • 19. Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sézary syndrome.
    Jothishankar B; Almazan T; Kim Y; Liauw S; Smith S; Kline J; Abdulla F
    Br J Haematol; 2019 Jul; 186(2):377-379. PubMed ID: 30937886
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS).
    Jothishankar B; Venkataraman G; Goldberg RC; Abdulla F
    Ann Diagn Pathol; 2019 Dec; 43():151404. PubMed ID: 31629155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.